{
  "id": "sah-2023",
  "title": "AHA/ASA Aneurysmal Subarachnoid Hemorrhage 2023",
  "shortTitle": "aSAH 2023",
  "doi": "10.1161/STR.0000000000000436",
  "publisherUrl": "https://www.ahajournals.org/doi/10.1161/STR.0000000000000436",
  "pdfUrl": "https://www.ahajournals.org/doi/pdf/10.1161/STR.0000000000000436",
  "recommendations": [
    {
      "section": "Natural History and Outcome of aSAH",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH, use of clinical scales (eg, the Hunt and Hess [HH] grade or World Federation of Neurosurgical Societies [WFNS] grade) is recommended to determine initial clinical severity and predict outcome.28,29",
      "page": 8
    },
    {
      "section": "Natural History and Outcome of aSAH",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with high-grade aSAH, aneurysm treatment is reasonable, after careful discussion of likely prognosis with family members, to optimize patient outcome.28,30",
      "page": 8
    },
    {
      "section": "Natural History and Outcome of aSAH",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH and advanced age, aneurysm treatment is reasonable, after careful discussion of prognosis with family members, to improve survival and outcome.31-33 3: No benefit B-NR 4. In patients with aSAH who do not improve after correction of modifiable conditions and are deemed unsalvageable because of evidence of irreversible neurological injury, treatment of the aneurysm is not beneficial.34,35",
      "page": 8
    },
    {
      "section": "Clinical Manifestations and Diagnosis of",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with acute onset of severe headache, prompt diagnostic workup and evaluation are recommended to diagnose/ exclude aSAH and minimize morbidity and mortality.43-46",
      "page": 9
    },
    {
      "section": "Clinical Manifestations and Diagnosis of",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with acute onset of severe headache who present >6 hours from symptom onset or who have a new neurological deficit, a noncontrast head CT and, if negative for aSAH, lumbar puncture (LP) should be performed to diagnose/exclude aSAH.47, 4 8",
      "page": 9
    },
    {
      "section": "Clinical Manifestations and Diagnosis of",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with acute onset of severe headache who present <6 hours from symptom onset and without new neurological deficit, a noncontrast head CT performed on a high-quality scanner and interpreted by a board-certified neuroradiologist is reasonable to diagnose/exclude aSAH.49-53",
      "page": 9
    },
    {
      "section": "Clinical Manifestations and Diagnosis of",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "4. In patients with acute onset of severe headache without a new neurological deficit, application of the Ottawa SAH Rule may be reasonable to identify those at high risk for aSAH.45,54,55 Evaluation for cause of aSAH",
      "page": 9
    },
    {
      "section": "Clinical Manifestations and Diagnosis of",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "5. In patients with spontaneous SAH with high level of concern for aneurysmal source and a negative or inconclusive CT angiography (CTA), digital subtraction angiography (DSA) is indicated to diagnose/exclude cerebral aneurysm(s).56-59",
      "page": 9
    },
    {
      "section": "Clinical Manifestations and Diagnosis of",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "6. In patients with SAH from confirmed cerebral aneurysm(s), DSA can be useful to determine the optimal strategy for aneurysm intervention.60,61 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 July 2023 e323 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 9
    },
    {
      "section": "Hospital Characteristics and Systems of Care",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. For patients with aSAH, timely transfer from hospitals with low case volume to higher-volume centers with multidisciplinary neurointensive care services, comprehensive stroke center capabilities, and experienced cerebrovascular surgeons/ neuroendovascular interventionalists is recommended to improve outcomes.67-77",
      "page": 11
    },
    {
      "section": "Hospital Characteristics and Systems of Care",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. For patients with aSAH, care should be provided in a dedicated neurocritical care unit by a multidisciplinary team.78-80",
      "page": 11
    },
    {
      "section": "Medical Measures to Prevent Rebleeding",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "C-EO",
      "text": "1. In patients with aSAH and unsecured aneurysm, frequent blood pressure (BP) monitoring and BP control with shortacting medication(s) is recommended to avoid severe hypotension, hypertension, and BP variability.",
      "page": 13
    },
    {
      "section": "Medical Measures to Prevent Rebleeding",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "C-EO",
      "text": "2. In patients with aSAH who are receiving anticoagulants, emergency anticoagulation reversal with appropriate reversal agents should be performed to prevent rebleeding. 3: No benefit A 3. In patients with aSAH, routine use of antifibrinolytic therapy is not useful to improve functional outcome.85-87",
      "page": 13
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. For patients with aSAH, surgical or endovascular treatment of the ruptured aneurysm should be performed as early as feasible after presentation, preferably within 24 hours of onset, to improve outcome.40,98-104 Treatment goal",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. For patients with aSAH, complete obliteration of the ruptured aneurysm is indicated whenever feasible to reduce the risk of rebleeding and retreatment.105-107",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "C-EO",
      "text": "3. For patients with aSAH in whom complete obliteration of the ruptured aneurysm by either clipping or primary coiling treatment is not feasible in the acute phase, partial obliteration to secure the rupture site and retreatment in a delayed fashion in those with functional recovery are reasonable to prevent rebleeding. Modality of treatment: general",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "4. For patients with aSAH from ruptured aneurysms of the posterior circulation that are amenable to coiling, coiling is indicated in preference to clipping to improve outcome.108-110",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "5. For patients with aSAH deemed salvageable and with depressed level of consciousness due to large intraparenchymal hematoma, emergency clot evacuation should be performed to reduce mortality.111,112",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "C-EO",
      "text": "6. For patients with aSAH, the ruptured aneurysm should be evaluated by specialist(s) with endovascular and surgical expertise to determine the relative risks and benefits of surgical or endovascular treatment according to patient and aneurysm characteristics. 2b B-R 7 . For patients >70 years of age with aSAH, the superiority of coiling or clipping to improve outcome is not well established.113,114",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "8. For patients <40 years of age with aSAH, clipping of the ruptured aneurysm might be considered the preferred mode of treatment to improve durability of the treatment and outcome.113,115 Modality of treatment: for aneurysms equally suitable for clipping and coiling",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "A",
      "text": "9. For patients with good-grade aSAH from ruptured aneurysms of the anterior circulation equally suitable for both primary coiling and clipping, primary coiling is recommended in preference to clipping to improve 1-year functional outcome.110,116",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "10. For patients with good-grade aSAH from ruptured aneurysms of the anterior circulation equally suitable for both primary coiling and clipping, both treatment options are reasonable to achieve favorable long-term outcome.108,109,117 Endovascular adjuncts",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "11. For patients with aSAH from ruptured wide-neck aneurysms not amenable to surgical clipping or primary coiling, endovascular treatment with stent-assisted coiling or flow diverters is reasonable to reduce the risk of rebleed.118,119",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "12. For patients with aSAH from ruptured fusiform/blister aneurysms, the use of flow diverters is reasonable to reduce mortality.120,121",
      "page": 14
    },
    {
      "section": "Surgical and Endovascular Methods for",
      "classOfRec": "III",
      "classNote": "Harm",
      "levelOfEvidence": "B-NR",
      "text": "13. For patients with aSAH from ruptured saccular aneurysms amenable to either primary coiling or clipping, stents or flow diverters should not be used to avoid higher risk of complications.122,123 Treatment of Ruptured Cerebral Aneurysms (Continued) Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES e328 July 2023 Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 14
    },
    {
      "section": "Anesthetic Management of Surgical and",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "1. In patients with aSAH, the intraoperative use of mannitol or hypertonic saline can be effective in reducing ICP and cerebral edema.135,136",
      "page": 17
    },
    {
      "section": "Anesthetic Management of Surgical and",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH, anesthetic goals should include minimizing postprocedural pain, nausea, and vomiting.137-140",
      "page": 17
    },
    {
      "section": "Anesthetic Management of Surgical and",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH, prevention of intraoperative hyperglycemia and hypoglycemia during aneurysm surgery is reasonable to improve outcomes.141-147",
      "page": 17
    },
    {
      "section": "Anesthetic Management of Surgical and",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "4. In patients with aSAH and an unsecured ruptured aneurysm, frequent intraoperative BP monitoring and BP control are reasonable to prevent ischemia and rerupture.148-153",
      "page": 17
    },
    {
      "section": "Anesthetic Management of Surgical and",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "5. In patients with aSAH, intraoperative neuromonitoring may be reasonable to guide anesthetic and operative management.154-159",
      "page": 17
    },
    {
      "section": "Anesthetic Management of Surgical and",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "6. In patients with aSAH and an uncontrolled intraoperative aneurysmal rupture, adenosine may be considered to facilitate aneurysm clip placement by inducing cardiac standstill and temporary profound pause.160,161 3: No benefit B-R 7 . In patients with good-grade aSAH, the routine use of induced mild hypothermia during aneurysm surgery is not beneficial.147 ,162-168",
      "page": 17
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH who require mechanical ventilation for >24 hours, implementation of a standardized ICU care bundle is recommended to reduce the duration of mechanical ventilation and hospital-acquired pneumonia.177,178 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 July 2023 e333 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 19
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH who develop severe acute respiratory distress syndrome (ARDS) and life-threatening hypoxemia, rescue maneuvers such as prone positioning and alveolar recruitment maneuvers with ICP monitoring may be reasonable to improve oxygenation.179-182 Intravascular volume and electrolyte management",
      "page": 20
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "3. In patients with aSAH, close monitoring and goal-directed treatment of volume status are reasonable to maintain euvolemia.183-185",
      "page": 20
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "4. In patients with aSAH, use of mineralocorticoids is reasonable to treat natriuresis and hyponatremia.186,187",
      "page": 20
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "III",
      "classNote": "Harm",
      "levelOfEvidence": "B-R",
      "text": "5. In patients with aSAH, induction of hypervolemia is potentially harmful because of the association with excess morbidity.188-190 Other",
      "page": 20
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "6. In patients with aSAH whose ruptured aneurysm has been secured, pharmacological or mechanical venous thromboembolism (VTE) prophylaxis is recommended to reduce the risk for VTE.191-193 2a B-NR 7 . In patients with aSAH, effective glycemic control, strict hyperglycemia management, and avoidance of hypoglycemia are reasonable to improve outcome.141,142,194,195",
      "page": 20
    },
    {
      "section": "Management of Medical Complications",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "8. In patients with aSAH with fever refractory to antipyretic medications, the effectiveness of therapeutic temperature management (TTM) during the acute phase of aSAH is uncertain.196-198",
      "page": 20
    },
    {
      "section": "Nursing Interventions and Activities",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-R",
      "text": "1. In patients with aSAH, use of evidencebased protocols and order sets is recommended to improve standardization of care.243-250",
      "page": 22
    },
    {
      "section": "Nursing Interventions and Activities",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH, frequent neurological assessment with a neurological assessment tool such as the GCS or National Institutes of Health Stroke Scale (NIHSS) is recommended to monitor DCI and other secondary complications.246,251-254",
      "page": 22
    },
    {
      "section": "Nursing Interventions and Activities",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH, frequent vital sign and neurological monitoring is recommended for detection of neurological change and prevention of secondary cerebral insults and poor outcomes.244,246,250,255-257 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES e336 July 2023 Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 22
    },
    {
      "section": "Nursing Interventions and Activities",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "4. In patients with aSAH, a validated dysphagia screening protocol should be implemented before initiation of oral intake to reduce the incidence of pneumonia.244,246,258-261",
      "page": 23
    },
    {
      "section": "Nursing Interventions and Activities",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "5. In patients with aSAH, specialized nursing stroke competencies and certification can be effective to positively affect outcomes, timeliness of care, and adherence to stroke protocols.248,262-264",
      "page": 23
    },
    {
      "section": "Nursing Interventions and Activities",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "C-LD",
      "text": "6. In patients with aSAH and a secured aneurysm, an early, evidence-based mobility algorithm is reasonable to improve level of function at discharge and global functional outcome at 12 months.249,265-268",
      "page": 23
    },
    {
      "section": "Monitoring and Detection of Cerebral",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH with suspected vasospasm or limited neurological examination, CTA or CT perfusion (CTP) can be useful to detect vasospasm and predict DCI.270-275",
      "page": 25
    },
    {
      "section": "Monitoring and Detection of Cerebral",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH, transcranial Doppler (TCD) ultrasound monitoring is reasonable to detect vasospasm and predict DCI.253,276-280",
      "page": 25
    },
    {
      "section": "Monitoring and Detection of Cerebral",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with high-grade aSAH, continuous EEG (cEEG) monitoring can be useful to predict DCI.276,280-292",
      "page": 25
    },
    {
      "section": "Monitoring and Detection of Cerebral",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "4. In patients with high-grade aSAH, invasive monitoring of brain tissue oxygenation, lactate/pyruvate ratio, and glutamate may be considered to predict DCI.293-305",
      "page": 25
    },
    {
      "section": "Management of Cerebral Vasospasm and",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "A",
      "text": "1. In patients with aSAH, early initiation of enteral nimodipine is beneficial in preventing DCI and improving functional outcomes.316-319",
      "page": 26
    },
    {
      "section": "Management of Cerebral Vasospasm and",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH, maintaining euvolemia can be beneficial in preventing DCI and improving functional outcomes.320,321",
      "page": 26
    },
    {
      "section": "Management of Cerebral Vasospasm and",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH and symptomatic vasospasm, elevating systolic BP values may be reasonable to reduce the progression and severity of DCI.322-325",
      "page": 26
    },
    {
      "section": "Management of Cerebral Vasospasm and",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "4. In patients with aSAH and severe vasospasm, use of intra-arterial vasodilator therapy may be reasonable to reverse cerebral vasospasm and reduce the progression and severity of DCI.326-335",
      "page": 26
    },
    {
      "section": "Management of Cerebral Vasospasm and",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "5. In patients with aSAH and severe vasospasm, cerebral angioplasty may be reasonable to reverse cerebral vasospasm and reduce the progression and severity of DCI.336-344 3: No benefit A 6. In patients with aSAH, routine use of statin therapy to improve outcomes is not recommended.345,346 3: No benefit A 7 . In patients with aSAH, routine use of intravenous magnesium to improve neurological outcomes is not recommended.347 ,348",
      "page": 26
    },
    {
      "section": "Management of Cerebral Vasospasm and",
      "classOfRec": "III",
      "classNote": "Harm",
      "levelOfEvidence": "B-R",
      "text": "8. For patients with aSAH at risk of DCI, prophylactic hemodynamic augmentation should not be performed to reduce iatrogenic patient harm.189,211,349,350 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES e340 July 2023 Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 26
    },
    {
      "section": "Management of Hydrocephalus Associated",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH and acute symptomatic hydrocephalus, urgent CSF diversion (EVD and/or lumbar drainage) should be performed to improve neurological outcome.236,384-387",
      "page": 30
    },
    {
      "section": "Management of Hydrocephalus Associated",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH and hydrocephalus who require an EVD, implementation and adherence to an EVD bundled protocol that addresses insertion, management, education, and monitoring are recommended to reduce complication and infection rates.388-396",
      "page": 30
    },
    {
      "section": "Management of Hydrocephalus Associated",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH and associated chronic symptomatic hydrocephalus, permanent CSF diversion is recommended to improve neurological outcome.397-400 3: No benefit C-LD 4. In patients with aSAH, routine fenestration of the lamina terminalis is not indicated for reducing the rate of shunt dependency.401",
      "page": 30
    },
    {
      "section": "Management of Seizures Associated",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH and either fluctuating neurological examination, depressed mental state, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, or cortical infarction, cEEG monitoring is reasonable to detect seizures.291,405,406",
      "page": 31
    },
    {
      "section": "Management of Seizures Associated",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH and high-seizurerisk features (ie, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, and cortical infarction), use of prophylactic antiseizure medication(s) may be reasonable to prevent seizures.407-413 3: No benefit B-R 3. In patients with aSAH without highseizure-risk features (ie, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, and cortical infarction), prophylactic treatment with antiseizure medication is not beneficial.406-408,410,414",
      "page": 31
    },
    {
      "section": "aSAH Acute Recovery",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH, use of validated grading scores or patient-reported outcome measures prior to hospital discharge is recommended to screen for physical, cognitive, behavioral, and QOL deficits.39,425-431",
      "page": 33
    },
    {
      "section": "aSAH Acute Recovery",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH, use of validated screening tools in the postacute period is recommended to identify post-aSAH depression and anxiety.429,432 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 July 2023 e347 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 33
    },
    {
      "section": "aSAH Acute Recovery",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH and depression, psychotherapy and pharmacotherapy are recommended to reduce symptoms of depression.429,432-435",
      "page": 34
    },
    {
      "section": "aSAH Acute Recovery",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "4. In patients with aSAH, use of a validated screening tool in the postacute period is useful to identify cognitive dysfunction.430,436-439",
      "page": 34
    },
    {
      "section": "aSAH Acute Recovery",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "5. In patients with aSAH, an early multidisciplinary team-based approach to treatment and rehabilitation is recommended to reduce LOS and identify discharge needs.231,440",
      "page": 34
    },
    {
      "section": "aSAH Acute Recovery",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "6. In patients with aSAH and no other medical or neurological contraindications, early rehabilitation after the ruptured aneurysm is secured is reasonable to improve functional outcome and reduce LOS.267 ,441-445 2b C-LD 7 . In patients with aSAH in a coma, early use of neurostimulants may be reasonable to promote consciousness recovery.446-448 3: No benefit A 8. In patients with aSAH without depression, fluoxetine therapy is not effective to enhance poststroke functional status.449-452",
      "page": 34
    },
    {
      "section": "aSAH Long-Term Recovery",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In adult patients with aSAH, screening and intervention for depression, anxiety, and sexual dysfunction are recommended to improve long-term outcomes.461-465",
      "page": 36
    },
    {
      "section": "aSAH Long-Term Recovery",
      "classOfRec": "IIa",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH, it is reasonable to choose the MoCA over the MMSE to identify cognitive impairment.438,466,467",
      "page": 36
    },
    {
      "section": "aSAH Long-Term Recovery",
      "classOfRec": "IIb",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "3. In patients with aSAH, counseling patients and caregivers on the high long-term risk of cognitive dysfunction can be beneficial to identify long-term needs.468 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES e350 July 2023 Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 36
    },
    {
      "section": "Risk Factors, Prevention, and Subsequent",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "1. In patients with aSAH who have undergone aneurysm repair, perioperative cerebrovascular imaging is recommended to identify remnants or recurrence of the aneurysm that may require further treatment.113,116,131",
      "page": 37
    },
    {
      "section": "Risk Factors, Prevention, and Subsequent",
      "classOfRec": "I",
      "classNote": null,
      "levelOfEvidence": "B-NR",
      "text": "2. In patients with aSAH who have undergone aneurysm repair, follow-up cerebrovascular imaging is recommended to identify recurrence or regrowth of the treated aneurysm, changes in another known aneurysm, or development of de novo aneurysm(s) that may require further treatment to reduce the risk of aSAH.116,131 Downloaded from http://ahajournals.org by on February 1, 2026 CLINICAL STATEMENTS AND GUIDELINES Stroke. 2023;54:e314-e370. DOI: 10.1161/STR.0000000000000436 July 2023 e351 Hoh et al Guideline for the Management of Patients With aSAH",
      "page": 37
    }
  ]
}